AbsorbMax
AbsorbMax, licence 80047489: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Bio Trust Nutrition LLC.
- NPN or DIN-HM
- 80047489
- Status
- Active licence
- Licence date
- 10 January 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Dipeptidyl aminopeptidase IV Source : Aspergillus flavus var. oryzae - Cellule entière | 2050.0 FCC HUT | Not calculated |
| Dipeptidyl aminopeptidase IV Source : Aspergillus flavus var. oryzae - Cellule entière | 7.46 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 3.03 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 100000.0 FCC PU | Not calculated |
| (1-4)-alpha-D-galacturonan glycanohydrolase Source : Aspergillus niger - En entier | 10.0 Endo-PG | Not calculated |
| (1-4)-alpha-D-galacturonan glycanohydrolase Source : Aspergillus niger - En entier | 1.0 mg | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 5.0 mg | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 150.0 FCC GalU | Not calculated |
| Protéase fongique Source : Aspergillus niger - En entier | 36.36 mg | Not calculated |
| Protéase fongique Source : Aspergillus niger - En entier | 200.0 FCC SAPU | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 180.71 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 10578.0 FCC HUT | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 3948.0 FCC PC | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 6.58 mg | Not calculated |
Non-medicinal ingredients
Gomme de gellane, Hypromellose, Eau, Carbonate de calcium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 3.0 Jour(s) |
Uses authorised in Canada
Cayenne is traditionally used in Herbal Medicine to aid digestion. Digestive enzymes. Alpha-galactosidase helps prevent gastrointestinal intolerance of oligosaccharides/fermentable carbohydrates. Protease helps digest proteins. Protease is a digestive aid.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Headaches, heartburn, bloating, gastralgia, and hypersensitivity/allergy has been known to occur; in which case, discontinue use. Nausea, vomiting, and diarrhoea have been known to occur, in which case discontinue use (and consult a health care practitioner).
- Contre-indications
Do not use if you are pregnant or breastfeeding.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you have stomach ulcers, inflammation, or diabetes. If you have a gastrointestinal lesion/ulcer, are taking an anticoagulant/blood thinner; an anti-inflammatory or antibiotic; or are having surgery, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80047489
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.